Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.

Also called NCT07227675

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 162 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07227675
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07227675. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-23 (actual); primary completion 2019-03-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
Acronym
COAPT CAS
Condition
Mitral Regurgitation
Condition
Mitral Valve Regurgitation
Intervention (Device)
MitraClip® NT System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct07227675
Content hash
c2330880e6a5c10ba37e3d43522b7d3c90fe98555d54dad8abce3b0902feb53f